Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Covalent Docking Identifies a Potent and Selective MKK7 Inhibitor
HTML
PDF
Details
Locations
Year:
2018
Type:
article
Source:
Cell chemical biology
DOI:
10.1016/j.chembiol.2018.10.011
Authors:
Amit Shraga,
Evgenia Olshvang,
Natalia Davidzohn,
Payam Khoshkenar,
Nicolas Germain,
Khriesto Shurrush,
Silvia Carvalho,
Liat Avram,
Shira Albeck,
Tamar Unger,
Bruce Lefker,
Chakrapani Subramanyam,
Robert L. Hudkins,
Amir Mitchell,
Ziv Shulman,
Takayoshi Kinoshita,
Nir London
show all 17
Institutions:
Weizmann Institute of Science,
University of Massachusetts Chan Medical School,
Pfizer (United States),
Teva Pharmaceuticals (United States),
Osaka Prefecture University
Language:
English
Topic:
Computational Drug Discovery Methods
Subfield:
Drug Discovery
Field:
Pharmacology, Toxicology and Pharmaceutics
Domain:
Life Sciences
Keywords:
MKK7,
JNK signaling,
kinase inhibitors,
MEK,
JNK phosphorylation,
kinase selectivity,
B cell activation,
lipopolysaccharide,
covalent docking
show all 9
Open Access status:
bronze
Funders:
Teva Pharmaceutical Industries,
Israel Science Foundation,
Institute for Protein Research, Osaka University
Award:
G431548031
OpenAlex ID:
W2900458600
FWCI:
2.759
Cites:
79
Cited by:
69
Related to:
10